Skip to main content
SpringerLink
Log in

Angioimmunoblastische Lymphadenopathie mit Dysproteinämie (AILD)

  • Chapter
Kompendium Internistische Onkologie

  • 11 Accesses

Zusammenfassung

Sehr seltene Krankheit, deren Inzidenz nicht näher angegeben werden kann. Sie kommt bei beiden Geschlechtern in gleicher Häufigkeit vor, der Altersgipfel liegt zwischen 50 und 70 Jahren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Boumpas DT, Wheby MS, Jaffe ES et al. (1990) Synovitis in angioimmunolblastic lymphadenopathy with dysproteinemia simulating rheumatoid arthritis. Rheum 33: 578 - 582

    CAS  Google Scholar 

  • Coupland RW, Pontifex AH, Salinas FA (1985) Angioimmunoblastic lymphadenopathy with dysproteinemia. Circulating immune complexes and the review of 18 cases. Cancer 55: 1902 - 1906

    Article  PubMed  CAS  Google Scholar 

  • Ferrer I, Vidaller A, Fernandez de Silva et al (1988) Peripheral neuropathy associated with angioimmunoblastic lymphadenopathy. Clin Neurol Neurosurg 90: 159 - 162

    Article  PubMed  CAS  Google Scholar 

  • Flandrin G, Daniel MY, El Yafi G et al. (1972) Sarcomatoses ganglionnaires diffuses a differenciation plasmacytaire avec anemie hemolytique auto-immune. Actual Hematol 6: 25 - 41

    Google Scholar 

  • Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy wirth dysproteinemia. Lancet I: 1070 - 1073

    Google Scholar 

  • Frizzera G, Peterson BA, Bayrd ED, Goldman A (1985). A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: Clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3: 1202 - 1216

    PubMed  CAS  Google Scholar 

  • Harris NL, Jaffe ES, Stein H et al. (1994) A revised european-american classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84: 1361-1392

    Google Scholar 

  • Knecht H (1989). Angioimmunoblastic lymphadenopathy: Experience and state of current knowledge. Semin Hematol 26: 208 - 215

    PubMed  CAS  Google Scholar 

  • Lennert K, Feller AC (1990). Histopathologie der Non-Hodgkin-Lymphome. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkins disease. N Engl J Med 292: 1-8

    Google Scholar 

  • Murayama T, Imoto S, Takahashi T et al. (1992) Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A. Cancer 69: 2567 - 2570

    Article  PubMed  CAS  Google Scholar 

  • Nathwani BN, Rappaport H, Moran EM et al. (1978) Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 41: 578 - 606

    Article  PubMed  CAS  Google Scholar 

  • Ohsaka A, Saito K, Sakai T et al. (1992) Clinicopathologic and therapeutic aspects of angioimmunoblastic lymphadenopathy-releated lesions. Cancer 69: 1259 - 1267

    Article  PubMed  CAS  Google Scholar 

  • Pangalis GA, Moran EM, Rappaport H (1978). Blood and bone marrow findings in angioimmunoblastic lymphadenopathy. Blood 51: 71 - 83

    PubMed  CAS  Google Scholar 

  • Pangalis GA, Moran EM, Nathwani BN et al. (1983) Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer 52: 318-321

    Google Scholar 

  • Radasziewicz T, Lennert K (1975) Lymphogranulomatosis X. Klinisches Bild, Therapie and Prognose. Dtsch Med Wochenschr 100: 1157-1163

    Google Scholar 

  • Schauer PK, Strauss DJ, Bagley CM et al. (1981) Angioimmunoblastic lymphadenopathy: Clinical spectrum of disease. Cancer 48: 2493-2498

    Google Scholar 

  • Schmitz N, Prange E, Haferlach T et al. (1991) High dose chemotherapy and autologous bone marrow transplantation in relapsing autoimmunoblastic lymphadenopathy with dysproteinemia. Bone Marrow Transplant 8: 503 - 506

    PubMed  CAS  Google Scholar 

  • Schwarzmeier JD, Reinisch WW, Kurkciyan IE et al. (1992) Interferon-a induces complete remission in angioimmunoblastic lymphadenopathy: Late development of aplastic anemia with cytokine abnormalities. Br J Hematol 79: 336-337

    Google Scholar 

  • Siegert W, Nerl C, Meuthen I et al. (1991) Recombinant human interferon-a in the treatment of angioimmunoblastic lymphadenopathy: Results in 12 patients. Leukemia 5: 892 - 896

    PubMed  CAS  Google Scholar 

  • Siegert W, Nerl C, Agthe A et al. (1994) Angioimmunoblastic lymphadenopathy ( AILD)-type T-cell lymphoma: Prognostic relevance of clinical and laboratory symptoms at presentation. Cancer Res Clin Oncol [Suppl] 120: R30

    Google Scholar 

  • Suchi T (1974) Atypical lymph node hyperplasia with fatal outcome. A report on the histopathological, immunological and clinical investigations of the cases. Recent Adv Res 14: 13 - 34

    Google Scholar 

  • Uphouse WJ, Woods JC (1987) Angioimmunoblastic lymphadenopathy with dysproteinemia. Complete remission with cisplatin-based chemotherapy. Cancer 60: 2161-2164

    Google Scholar 

Download references

Authors
  1. P. S. Mitrou
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik, Innere Medizin IV, Abteilung Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06120, Halle/Saale, Deutschland

    Hans-Joachim Schmoll (Direktor) (Direktor)

  2. Klinik und Poliklinik für Innere Medizin II, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, D-07740, Jena, Deutschland

    Klaus Höffken (Direktor) (Direktor)

  3. Medizinischen Klinik II, Schwerpunkt Onkologie und Hämatologie, Humboldt-Universität, Universitätsklinikum Charité, Schumannstraße 20/21, D-10117, Berlin, Deutschland

    Kurt Possinger (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mitrou, P.S. (1997). Angioimmunoblastische Lymphadenopathie mit Dysproteinämie (AILD). In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12175-7_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60830-1

  • Online ISBN: 978-3-662-12175-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation